Format

Send to

Choose Destination
Am J Cardiol. 2005 Jan 15;95(2):283-6.

Comparison of angiotensin-converting enzyme inhibitors in the treatment of congestive heart failure.

Author information

1
Institute for Clinical Evaluative Sciences, G106-2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada. karen.tu@ices.on.ca

Abstract

The effectiveness of the different angiotensin-converting enzyme (ACE) inhibitors in the treatment of patients with congestive heart failure (CHF) was compared by performing a retrospective cohort study using linked administrative databases on elderly patients admitted to the hospital for the treatment of CHF. Relative to those initiated on enalapril, no significant differences in the combined end point of readmission to the hospital for CHF or mortality were observed among users of lisinopril, ramipril, or other ACE inhibitors. In terms of effectiveness for the treatment of patients with CHF, the findings of this study suggest a class effect among ACE inhibitors.

PMID:
15642572
DOI:
10.1016/j.amjcard.2004.08.097
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center